Ebola Drugmaker Shares Surge After CDC Confirms First US Case

Shares of Tekmira Pharmaceuticals, which is working on a treatment for Ebola, are surging in after hours trade after the Centres for Disease Control confirmed the first case of Ebola in the US.

Shares of Tekmira were up as much 11% on Tuesday evening. Shares of BioCryst Pharmaceuticals, which is also working to develop an Ebola treatment, were also up more than 14% in after hours trade on Tuesday.

Other pharmaceutical companies, including Sarepta Therapeutics, up 7%, and NewLink Genetics, up 14.5% were also higher following the news.

All of these companies, in some form or fashion, have been working on treatments for Ebola.

The CDC is set to hold a press conference at 5:30 pm ET on Tuesday.

More to come …

NOW WATCH: Money & Markets videos

Want to read a more in-depth view on the trends influencing Australian business and the global economy? BI / Research is designed to help executives and industry leaders understand the major challenges and opportunities for industry, technology, strategy and the economy in the future. Sign up for free at research.businessinsider.com.au.